Another issue we see at Juventas Wellness is nutrient deficiency
In August 2025, semaglutide became the first GLP-1 medication to receive FDA approval specifically for treating MASH
Assessing the true impact of pharmacological treatments such as GLP-1RAs on BC remains challenging due to variability in study populations, treatment durations, concurrent lifestyle interventions, and the lack of standardised methods for evaluating LBM and FM
Emotional anguish: Compensation for the anxiety, depression, and mental toll of living with a chronic, debilitating condition
[DOI] [PubMed] [Google Scholar] Stubiger G., Belgacem O., Rehulka P., Bicker W., Binder B
Florida heat can affect GLP-1 medication stability and injection safety